胫骨横向骨搬移治疗合并慢性肾病的糖尿病足
DOI:
作者:
作者单位:

广西医科大学第一附属医院

作者简介:

通讯作者:

中图分类号:

基金项目:

基于ITS探讨软骨下骨rod-plate微结构重塑在骨关节炎发 病机制中的作用,国家自然科学基金项目;胫骨皮质横向牵张激活SSCs及HIF-1α/CXCL12/CXCR4通路对踝关节OA骨-软骨 再生的作用及机制;


Treatment of diabetic foot combined with chronic kidney disease using Tibia Transverse Transport
Author:
Affiliation:

1.The First Affiliated Hospital of Guangxi Medical University;2.the First Affiliated Hospital of Guangxi Medical University

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:[目的] 研究胫骨横向骨搬移(Tibia Transverse Transport, TTT)治疗合并慢性肾病(Chronic Kidney Disease,CKD) 的糖尿病足溃疡(Diabetic foot ulcer,DFU)的临床疗效。 [方法] 回顾性分析本院收治的120例重度糖尿病足(Wagner 3或4级)患者的临床资料,根据是否合并慢性肾病将患者分为DFU+CKD组(n=67)和DFU组(n=53)。两组患者年龄、性别占比、糖尿病足病程、足部坏疽率、溃疡感染的IDSA/IWGDF分级等差异均无统计学意义(P>0.05)。DFU+CKD组有更高比例的患者有下肢大动脉严重狭窄(>=80%管腔直径)(P<0.05),且有95.5%的患者处于慢性肾病Ⅲ期-Ⅴ期。比较两组患者溃疡愈合率、愈合时间、保肢率、复发率、术后1年生存率及影像学和实验室检查指标等。 [结果] 两组均无明显手术并发症。所有患者均获得随访,时长1年。DFU+CKD组7例患者因心脑血管疾病死亡,生存率为89.6%,而DFU组患者均存活。DFU+CKD组存活患者术后1年的愈合率为91.7%,愈合时间为4.7±2.9月,保肢率为90%,复发率为11.7%。,DFU组愈合率为94.3%,愈合时间为3.1±1.7月,保肢率为96.2%,复发率为1.9%。两组的愈合率、保肢率、复发率比较均无统计学差异(P>0.05)。DFU+CKD组的愈合时间更长 (P<0.05)。计算机断层血管成像(CTA)显示DFU+CKD组术后1月足部的微血管明显增多。DFU+CKD组术后1月CRP水平、血肌酐及HbA1c较术前明显下降(P<0.001),内生肌酐清除率显著增高(P<0.001) 。[结论] TTT治疗合并慢性肾病的DFU取得愈合率、保肢率较高,复发率较低的良好效果,机制可能与TTT促进足部微血管增生相关。

    Abstract:

    Abstract: [Objective] To compare the clinical efficacy of Tibia Transverse Transfer (TTT) in the treatment of diabetic foot ulcer (DFU) patients with chronic kidney disease (CKD). [Methods] The clinical data of 120 patients with severe DFU (Wagner grade 3 or 4) admitted to our hospital were retrospectively analyzed. The patients were divided into the DFU+CKD group (n=67) and DFU group (n=53) according to the CKD status. , and 95.5% of patients had chronic kidney disease in stage III-V. There was no statistically significant differences between the two groups in age, gender proportion, duration of diabetic foot, foot gangrene rate, IDSA/IWGDF grade of ulcer infection, etc.(P>0.05). The ulcer healing rate, healing time, limb salvage rate, recurrence rate, survival rate and imaging and laboratory data were compared between the two groups. [Results] No serious complications were found for either group. All patients were followed up for 1 year. Seven patients in the DFU+CKD group died of cardiovascular and cerebrovascular diseases, and the survival rate was 89.6%. No patients in the DFU group died and the survival rate was 100% (P<0.05). For the DFU+CKD group, the healing rate of the surviving patients was 91.7%, the healing time was 4.7±2.9 months, the limb salvage rate was 90%, and the recurrence rate was 11.7%.For the DFU group, the healing rate was 94.3%, the healing time was 3.1±1.7 months, the limb salvage rate was 96.2%, and the recurrence rate was 1.9%. There was no significant differences in healing rate, limb salvage rate, and recurrence rate between the groups (P>0.05).The DFU+CKD group had significant longer healing time than the DFU groups (P<0.05). Computed tomography angiography (CTA) showed that the DFU+CKD group had more small vessels 1 month postoperatively than preoperatively. Moreover, the DFU+CKD group had lower CRP, creatinine, and HbA1c and higher endogenous creatinine clearance rate 1 month postoperatively than preoperatively. [Conclusion] Treatment of DFU with CKD using TTT resulted in high ulcer healing rate and limb salvage rage. The mechanism is probably related to the formation of neovascularization at the foot stimulated by TTT.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-10-12
  • 最后修改日期:2021-12-21
  • 录用日期:2022-04-02
  • 在线发布日期:
  • 出版日期: